Back to company

BOOST Pharma ApS: Financial statements 2021

CVR: 41120495

BOOST Pharma ApS (CVR 41120495) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -1,319,978 and a net result of DKK -2,224,194 compared with DKK -63,347 the year before. Equity amounted to DKK -2,247,539. The company had 1 employee in the financial year.

Gross Profit
-1,319,978 kr.
Profit/Loss
-2,224,194 kr.
Equity
-2,247,539 kr.
Total Assets
7,823,001 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021--1.3 mio.-2.2 mio.-2.2 mio.1
2020--21 t.-63 t.-23 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like BOOST Pharma ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2021

Ingelise Saunders joins the board of BOOST Pharma ApSMay 1, 2021

As of May 1, 2021, Ingelise Saunders has joined the board of directors of BOOST Pharma ApS.

Lars Magnus Reinhold Westgren joins the board of BOOST Pharma ApSMay 1, 2021

As of May 1, 2021, Lars Magnus Reinhold Westgren has joined the board of directors of BOOST Pharma ApS.

Anna Cecilia Götherström steps down as director of BOOST Pharma ApSMay 1, 2021

As of May 1, 2021, Anna Cecilia Götherström has stepped down as director of BOOST Pharma ApS.

Lars Magnus Reinhold Westgren steps down as director of BOOST Pharma ApSMay 1, 2021

As of May 1, 2021, Lars Magnus Reinhold Westgren has stepped down as director of BOOST Pharma ApS.

BOOST Pharma ApS: The 2020 annual report is outMar 26, 2021

BOOST Pharma ApS has published its annual report for 2020. Gross profit came to DKK -20,919, and the net result was DKK -63,347.

BOOST Pharma ApS appoints new auditorFeb 22, 2021

As of February 22, 2021, BAKER TILLY DENMARK GODKENDT REVISIONSAKTIESELSKAB has been appointed auditor of BOOST Pharma ApS.

About BOOST Pharma ApS

BOOST Pharma ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2020. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Hans Thalsgård Schambye. The company is owned by BOOST Pharma AB. In 2025, the company reported a gross profit of DKK -7,557,572 and a net result of DKK -9,243,488 compared with DKK -4,259,583 the year before. Equity amounted to DKK -11,850,535.

Other financial years